JP2005525318A - 脂漏症および座瘡の処置のためのリノール酸エチルおよびクエン酸トリエチルに基づく組成物 - Google Patents
脂漏症および座瘡の処置のためのリノール酸エチルおよびクエン酸トリエチルに基づく組成物 Download PDFInfo
- Publication number
- JP2005525318A JP2005525318A JP2003561703A JP2003561703A JP2005525318A JP 2005525318 A JP2005525318 A JP 2005525318A JP 2003561703 A JP2003561703 A JP 2003561703A JP 2003561703 A JP2003561703 A JP 2003561703A JP 2005525318 A JP2005525318 A JP 2005525318A
- Authority
- JP
- Japan
- Prior art keywords
- acne
- acid
- composition
- skin
- triethyl citrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/008—Preparations for oily skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Birds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
・皮脂の産生の増大(脂漏症)
・毛包脂腺管の異常な角質化
・細菌のコロニー形成
本発明に基づいて、試験を実行して、皮脂測定デバイスを用いる臨床試験によって座瘡の処置について、2つの生成物、ローションおよびクリームの作用を実験的に評価した。
この試験は、試験されている生成物が、座瘡に対する処置において有効な補助であるか、そしてそれらが、座瘡の病巣の存在に起因する赤化を緩和できるかを評価することができる。
皮膚が脂ぎっており、かつ座瘡に罹患している15〜28歳の5例の女性ボランティア。
サンプルは、あるがままの、その使用特徴に基づいて、適用されなければならない。
サンプルは、そのボランティアに渡された説明カードに示される指示に従って、顔面の特定の部分に均一に適用されなければならない。
試験のためのボランティアを見つけた後、以下の計測的評価を実行する:
→EEC規則に従って認可された皮脂計測デバイス(SKIN LAB(登録商標))を用いる基礎的な皮脂の測定
→EEC規則に従って認可された装置(SKIN LAB(登録商標))を用いる基礎水和反応
→EEC規則に従って認可された装置(Tewameter(登録商標))を用いる基礎的なTEWL − 顔面の左側のみ
→偏光を備えるビデオカメラ(VIDEOCAP)を用いる、20×の倍率、できれば200×での顕微鏡写真の撮影。座瘡に起因するわずかな吹き出物を徹底的に可視化して、検査における処置の間のあらゆる改善を強調するためにはマイクロ画像が必要である。
→Mini DVを用いる顕微鏡写真の撮影。全身的な開始状況を規定するには、そして生成物の使用の間のあらゆる顕微鏡的な改善を実証するためには、写真が有用である。
ここで、以下は、本発明による処方物のいくつかの例である。
N° 説明 %w/w
01 リノール酸エチル 20.00
02 クエン酸トリエチル 80.00
調製の方法:02に01を混合する
N° 説明 %w/w
01 リノール酸エチル 20.00
02 クエン酸トリエチル 20.00
03 サリチル酸 2.00
04 エチル酸 58.00
調製の方法:04に03を溶解する;この溶液へ01+02を混合する
N° 説明 %w/w
A相
01 リノール酸エチル 5.00
02 クエン酸トリエチル 5.00
03 パルミチン酸アスコルビル 1.50
04 Ppg−15ステアリルエーテル 10.00
05 カプリオイルグリシン 4.00
06 Steareth−2 3.00
07 Steareth−21 2.00
B相
08 防腐剤 必要分
09 グリセロール 3.00
10 水 必要分
調製方法:A相、01+02+03+04+05+06+07を混合して、75℃に加熱する;B相、08+09+10を混合して、このプレ混合物を+75℃まで加熱し、次いで撹拌しながらA相にB相を添加する。常に撹拌しながら室温まで冷却する。
N° 説明 %w/w
01 リノール酸エチル 20.00
02 クエン酸トリエチル 20.00
03 エリスロマイシン 10.00
04 エチル酸 50.00
調製の方法:04に03を溶解し、この溶液中で01+02を混合する
N° 説明 %w/w
01 トランス−レチノイン酸 0.025
02 リノール酸エチル 5.00
03 クエン酸トリエチル 20.00
04 エチル酸 必要分
調製の方法:04中に01+02+03を溶解する
N° 説明 %w/w
01 クリンダマイシン 1.00
02 リノール酸エチル 5.00
03 クエン酸トリエチル 20.00
04 エチル酸 必要分
調製方法:02+03+04を混合し、次にそれに01を溶解する。
Claims (8)
- 皮膚の美的状態を処置し、かつ改善するための局所用途のための組成物であって、活性成分として、リノール酸エチルおよびクエン酸トリエチルの混合物を含む組成物。
- リノール酸エチルが、0.1重量%〜99重量%の量で、そしてクエン酸トリエチルが99重量%〜0.1重量%の量で含まれるという点で特徴付けられる、請求項1に記載の局所用途のための組成物。
- さらに、酢酸、乳酸、サリチル酸、酒石酸、グリコール酸、クリンダマイシン、ミノサイクリン、エリトロマイシン、メトロニダゾール、アモキシシリン、トリクロサン、カプリオイルグリシン、アゼライン酸、水酸化亜鉛、塩化亜鉛、ビタミンAトランスレチノイン酸、レゾルシノール、ヒアルロン酸、ゲンタマイシン、メクロサイクリン、フェノール、アスコルビン酸、トコフェノール、リポ酸、ホスファチジルコリン、ホスファチジルセリン、クロルヘキシジン、イルガサン、アダパレン、リン脂質全般、全ての右旋性、左旋性型、ラセミ混合物、シス型、トランス型および関連の塩、エステルおよびアミドのように、単独でまたは組み合わせて用いられ、そして外用の特定の添加物および賦形剤の基剤中に処方される活性成分を含む、請求項1および2に記載の局所用途のための組成物。
- 添加された活性成分が、0.001〜90重量%、好ましくは0.5〜15重量%の量で含まれる、請求項3に記載の局所用途のための組成物。
- 外用のための組成物、例えば、油中水型エマルジョン、水中油型エマルジョン、単相溶液、二重相擬溶液、単相ゲル、二重相ゲルまたはサブミセルゲル、無水軟膏、パウダースプリンクラー、アルコラート、アルコール溶液、水アルコール溶液中に調製される、請求項1および2に記載の局所用途のための組成物。
- 脂漏症、座瘡、および酒さ性座瘡の処置のための請求項1および2に記載の組成物の使用。
- 皮膚の処置のため、詳細には脂漏症、座瘡、および酒さ性座瘡の処置のための方法であって、リノール酸エチルおよびクエン酸トリエチルの混合物を含む組成物を用いる工程、ならびに脂漏症、座瘡、および酒さ性座瘡に冒された皮膚の部分に対して局所的に、皮脂のトリグリセリドの構造的完全性を保持するのに十分な時間かつ量の組成物を適用して、これによって組成物が、細菌リパーゼおよび皮膚エステラーゼの部分に対するトリグリセリドの事前消化を低減するように、細菌リパーゼまたは皮膚エステラーゼの作用に対する優先基質を提供する工程、
を包含する、方法。 - 請求項7に記載の方法であって、これによって、リノール酸エチルおよびクエン酸トリエチルの混合物を含む組成物が、細菌リパーゼおよび皮膚エステラーゼによるリノール酸エチルおよびクエン酸トリエチルの各々の酸型への変換のために皮膚に適用され、それによって脂漏症、座瘡、および酒さ性座瘡の原因に対して直接または間接的に作用可能な活性成分が形成される、方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITBS2001A000111 | 2001-12-20 | ||
IT2001BS000111A ITBS20010111A1 (it) | 2001-12-20 | 2001-12-20 | Composizione per uso topico a base dell'estere etilico dell'acido linoleico e e del trietil estere dell'acido citrico associati con opportun |
PCT/IT2002/000791 WO2003061766A1 (en) | 2001-12-20 | 2002-12-13 | Composition based on etyllinoleate and triethylcitrate for the treatment of seborrhea and acne |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2005525318A true JP2005525318A (ja) | 2005-08-25 |
JP5257913B2 JP5257913B2 (ja) | 2013-08-07 |
Family
ID=11440808
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003561703A Expired - Lifetime JP5257913B2 (ja) | 2001-12-20 | 2002-12-13 | 脂漏症および座瘡の処置のためのリノール酸エチルおよびクエン酸トリエチルに基づく組成物 |
Country Status (14)
Country | Link |
---|---|
US (1) | US7169811B2 (ja) |
EP (1) | EP1455899B1 (ja) |
JP (1) | JP5257913B2 (ja) |
KR (1) | KR101057848B1 (ja) |
CN (1) | CN100374109C (ja) |
AT (1) | ATE515253T1 (ja) |
AU (1) | AU2002367451B8 (ja) |
CA (1) | CA2470199C (ja) |
ES (1) | ES2368815T3 (ja) |
IT (1) | ITBS20010111A1 (ja) |
NZ (1) | NZ533530A (ja) |
PL (1) | PL210279B1 (ja) |
RU (1) | RU2313338C2 (ja) |
WO (1) | WO2003061766A1 (ja) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7689225B2 (en) * | 2002-01-28 | 2010-03-30 | Ntt Docomo, Inc. | Method and apparatus for dormant mode support with paging |
ITBS20020078A1 (it) * | 2002-09-02 | 2004-03-03 | Paoli Ambrosi Gianfranco De | Composizione a base di trietil citrato nel trattamento delle infezioni di origine batterica della cute. |
US20040248982A1 (en) * | 2003-06-09 | 2004-12-09 | Dyer Gordon Wayne | Use of compounds for the inhibition of proteins and UV protection |
US20100204323A1 (en) * | 2004-12-09 | 2010-08-12 | The Dial Corporation | Antimicrobial compositions comprising organic acid esters and methods for reducing virus and bacterial populations using such compositions |
ITBS20050154A1 (it) * | 2005-12-06 | 2007-06-07 | Paoli Ambrosi Gianfranco De | Composizione a base di trietil citrato nella prevenzione dell'idrolisi enzimatica dei trigliceridi |
US7897800B2 (en) | 2006-02-03 | 2011-03-01 | Jr Chem, Llc | Chemical compositions and methods of making them |
US7687650B2 (en) | 2006-02-03 | 2010-03-30 | Jr Chem, Llc | Chemical compositions and methods of making them |
US7927614B2 (en) | 2006-02-03 | 2011-04-19 | Jr Chem, Llc | Anti-aging treatment using copper and zinc compositions |
US8647682B2 (en) * | 2006-06-30 | 2014-02-11 | Audrey Kunin | Composition and method for treating keratosis pilaris |
US7867522B2 (en) | 2006-09-28 | 2011-01-11 | Jr Chem, Llc | Method of wound/burn healing using copper-zinc compositions |
US8273791B2 (en) | 2008-01-04 | 2012-09-25 | Jr Chem, Llc | Compositions, kits and regimens for the treatment of skin, especially décolletage |
BRPI0908518A2 (pt) * | 2008-03-17 | 2015-09-29 | Glenmark Pharmaceuticals Ltd | formulação tópica de doses fixa estável, e, uso da formulação tópica de dose fixa estável |
WO2010085753A1 (en) | 2009-01-23 | 2010-07-29 | Jr Chem, Llc | Rosacea treatments and kits for performing them |
FR2954124B1 (fr) * | 2009-12-18 | 2012-04-06 | Fabre Pierre Dermo Cosmetique | Utilisation du 2,3-dihydroxypropyl dodecanoate pour le traitement de la seborrhee |
US8952057B2 (en) | 2011-01-11 | 2015-02-10 | Jr Chem, Llc | Compositions for anorectal use and methods for treating anorectal disorders |
JP6091431B2 (ja) * | 2011-01-31 | 2017-03-15 | ルコラス−エム.ディー.リミテッド | 医薬的使用 |
RU2519330C2 (ru) * | 2011-10-31 | 2014-06-10 | Открытое Акционерное Общество "Татхимфармпрепараты" | Композиция для наружного применения, обладающая противовоспалительной, анальгетической, антиревматоидной и антибактериальной активностью и способ ее получения |
ITBS20120126A1 (it) * | 2012-08-01 | 2014-02-02 | Paoli Ambrosi Gianfranco De | Composizione antibatterica per uso topico |
CN105997775A (zh) * | 2016-05-10 | 2016-10-12 | 赫尔森江苏医药有限公司 | 珍珠祛痘膏及其制作工艺 |
JP2021500369A (ja) * | 2017-10-24 | 2021-01-07 | グレンマーク・ファーマシューティカルズ・リミテッド | アダパレン及びミノサイクリンの局所用医薬組成物 |
CA3079789A1 (en) | 2017-11-28 | 2019-06-06 | C-Lecta Gmbh | Method for producing trehalose employing a trehalose phosphorylase variant |
KR102170815B1 (ko) * | 2019-11-11 | 2020-10-29 | 대봉엘에스 주식회사 | 지방산 또는 지방산 유도체를 포함하는 보습 또는 항아토피용 조성물 |
CN113456570A (zh) * | 2021-07-23 | 2021-10-01 | 完美(广东)日用品有限公司 | 一种祛痘组合物、祛痘啫喱及其制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2452119A1 (de) * | 1974-11-02 | 1976-05-13 | Henkel & Cie Gmbh | Kosmetische zubereitungen fuer die behandlung von akne |
JPH01110610A (ja) * | 1987-10-22 | 1989-04-27 | Lion Corp | ニキビ予防剤 |
AU1509799A (en) * | 1997-12-05 | 1999-06-28 | Chong Kun Dang Corporation | Pharmaceutical composition containing cyclosporin |
US6028067A (en) * | 1997-12-05 | 2000-02-22 | Chong Kun Dang Corp. | Cyclosporin-containing microemulsion preconcentrate composition |
US6063762A (en) * | 1997-12-05 | 2000-05-16 | Chong Kun Dang Corp. | Cyclosporin-containing microemulsion preconcentrate composition |
US6267985B1 (en) * | 1999-06-30 | 2001-07-31 | Lipocine Inc. | Clear oil-containing pharmaceutical compositions |
ITBS20010046A1 (it) * | 2001-06-20 | 2002-12-20 | Paoli Ambrosi Gianfranco De | Composizione per uso topico a base dell'estere etilico dell'acido linoleico e del trietil estere dell'acido citrico associati con opport |
-
2001
- 2001-12-20 IT IT2001BS000111A patent/ITBS20010111A1/it unknown
-
2002
- 2002-12-13 NZ NZ533530A patent/NZ533530A/en unknown
- 2002-12-13 AU AU2002367451A patent/AU2002367451B8/en not_active Ceased
- 2002-12-13 JP JP2003561703A patent/JP5257913B2/ja not_active Expired - Lifetime
- 2002-12-13 RU RU2004118419/15A patent/RU2313338C2/ru not_active IP Right Cessation
- 2002-12-13 CA CA2470199A patent/CA2470199C/en not_active Expired - Fee Related
- 2002-12-13 AT AT02806573T patent/ATE515253T1/de active
- 2002-12-13 ES ES02806573T patent/ES2368815T3/es not_active Expired - Lifetime
- 2002-12-13 WO PCT/IT2002/000791 patent/WO2003061766A1/en active IP Right Grant
- 2002-12-13 EP EP02806573A patent/EP1455899B1/en not_active Expired - Lifetime
- 2002-12-13 CN CNB028255534A patent/CN100374109C/zh not_active Expired - Fee Related
- 2002-12-13 PL PL370795A patent/PL210279B1/pl unknown
- 2002-12-13 KR KR1020047009506A patent/KR101057848B1/ko active IP Right Grant
- 2002-12-16 US US10/322,566 patent/US7169811B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
NZ533530A (en) | 2005-05-27 |
CN1606462A (zh) | 2005-04-13 |
RU2313338C2 (ru) | 2007-12-27 |
RU2004118419A (ru) | 2005-04-10 |
ATE515253T1 (de) | 2011-07-15 |
JP5257913B2 (ja) | 2013-08-07 |
AU2002367451B2 (en) | 2009-02-26 |
US7169811B2 (en) | 2007-01-30 |
ITBS20010111A1 (it) | 2003-06-20 |
EP1455899A1 (en) | 2004-09-15 |
CN100374109C (zh) | 2008-03-12 |
KR101057848B1 (ko) | 2011-08-19 |
KR20040068272A (ko) | 2004-07-30 |
PL210279B1 (pl) | 2011-12-30 |
PL370795A1 (en) | 2005-05-30 |
ES2368815T3 (es) | 2011-11-22 |
EP1455899B1 (en) | 2011-07-06 |
CA2470199A1 (en) | 2003-07-31 |
WO2003061766A1 (en) | 2003-07-31 |
AU2002367451B8 (en) | 2009-03-26 |
CA2470199C (en) | 2011-10-18 |
US20030118623A1 (en) | 2003-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5257913B2 (ja) | 脂漏症および座瘡の処置のためのリノール酸エチルおよびクエン酸トリエチルに基づく組成物 | |
AU2002367451A1 (en) | Composition based on ethyl ester of linoleic acid and triethyl ester of citric acid for topical use in the treatment of seborrhoea and acne | |
EP0229561B1 (fr) | Composition pharmaceutique, notamment dermatologique, ou cosmétique, à base de phases lamellaires lipidiques hydratées ou de liposomes contenant un rétinoîde ou un analogue structural dudit rétinoîde tel qu'un caroténoîde | |
JPH07277918A (ja) | 化粧用又は皮膚科用の組成物及びその製造法 | |
JPH10502944A (ja) | 皮膚科的疾患の処理のための組成物類及びそれらの使用方法 | |
KR20110036683A (ko) | 피부 치료용 벤조일 퍼옥사이드 조성물 | |
CN111249440A (zh) | 小分子短肽在制备治疗痤疮的产品中的应用 | |
EP1269991A2 (en) | Composition for topical use based on the ethylic ester of linoleic acid and on the triethyl ester of citric acid associated with suitable synergists | |
Kwon et al. | Reduction of enlarged facial pore using ion‐paired amino acid through enhancement in skin permeation and exfoliation: A placebo‐controlled in vivo study | |
JP7246926B2 (ja) | 多機能性の構造化されたグリシド/非グリシドマトリックス | |
JP3258801B2 (ja) | 皮膚新陳代謝促進剤 | |
US20060165813A1 (en) | Topical composition for treatment of skin disorders | |
US20220331269A1 (en) | Compositions for treating acne | |
WO2018148795A1 (en) | Compositions for treating acne | |
JPS63243014A (ja) | 美白化粧料 | |
JPH0529007B2 (ja) | ||
Webster et al. | Part III: Active Delivery, Formulation, and Testing | |
Rhein et al. | Sebum: physical-chemical properties, macromolecular structure, and effects of ingredients | |
Leyden | New Understandings of acne pathogenesis | |
AU2003257240A1 (en) | A topical composition for treatment of skin disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20051122 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090519 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090818 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20091013 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20100210 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20121113 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20121116 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20121214 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20121219 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20130111 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20130117 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130214 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20130417 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20160502 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5257913 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |